The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

• The continuous renal replacement therapy (CRRT) market has grown from $1.41 billion in 2023 to $1.57 billion in 2024, with a CAGR of 10.9%.
• By 2028, the market is expected to reach $2.38 billion, growing at a CAGR of 11.1%.

Key Drivers of Market Growth

• Chronic Kidney Disease: Rising incidences of chronic kidney disease are fueling market growth.
• Diabetes and Hypertension: Increasing rates of these conditions contribute to higher demand for CRRT.
• Healthcare Infrastructure: Investments in healthcare infrastructure support market expansion.
• ICU Admissions: A growing number of ICU admissions drives the need for CRRT.
• Pediatric Care: Expanding applications in pediatric care further boost the market.

Future Market Trends

• Technological Advancements: Rapid innovations and launches of new CRRT technologies.
• Product Innovation: Focus on advanced CRRT platforms with enhanced features.
• Increased Applications: Expanding uses in various medical fields.
• Technological Integration: Incorporation of advanced technologies in CRRT systems.

View More On The Continuous Renal Replacement Therapy Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/continuous-renal-replacement-therapy-global-market-report

Increasing Incidence of Chronic Kidney Disease Driving Market Expansion

• Chronic Kidney Disease (CKD): CKD leads to progressive loss of kidney function, driving the need for CRRT.
• Lifestyle and Aging: Rising lifestyle changes, aging populations, and increasing diabetes rates contribute to higher CKD incidences.
• Statistical Insights: In July 2022, the CDC reported that 37 million people in the US were affected by kidney disease. The Australian Institute of Health and Welfare noted a rise in kidney replacement therapy cases in 2020.

Major Players in the Continuous Renal Replacement Therapy Market

• Leading Companies: Medtronic, Fresenius Medical Care, Baxter International, B. Braun Melsungen, and others.
• Innovative Products: Companies are focusing on developing advanced CRRT platforms with new features and capabilities.

Innovative Developments in CRRT Platforms

• Advanced Technologies: Development of next-generation CRRT platforms with enhanced features.
• Example: In May 2021, Baxter International launched the Prismax 2 platform, which simplifies CRRT delivery and includes features like the Prismalung+ blood-gas exchanger for managing acute respiratory dysfunction.

Strategic Acquisitions and Regional Insights

• Baxter’s Acquisition: Baxter acquired Hillrom in December 2021 to expand its product portfolio and expertise in medical technology.
• Regional Growth: North America was the largest market in 2023, while Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Market Segmentation

• By Product: System, Consumables.
• By Therapy: Renal, Non-Renal.
• By Modality: SCUF, CVVH, CVVHD, CVVHDF.
• By Age Group: Adults, Pediatrics or Neonates.
• By End-Users: Hospitals, Ambulatory Care, Homecare.

The continuous renal replacement therapy market is poised for significant growth, driven by technological advancements, increasing chronic kidney disease incidences, and expanding applications across various patient demographics.

Request A Sample Of The Global Continuous Renal Replacement Therapy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15777&type=smp